Global Neglected Tropical Disease Treatment Market worth USD 2.13 Billion, at 5% CAGR during 2019-2023 | Technavio

June 11, 2019 Off By BusinessWire

LONDON–(BUSINESS WIRE)–#DiseaseTreatment–According to Technavio Research Report ” Global Neglected
Tropical Disease Treatment Market by type (antiparasitic drugs,
antibacterial drugs, and antiviral drugs) and geographic regions (ROW,
Asia, and North America)
is witnessed to grow by USD 2.13
billion, at a CAGR of 5% from 2019 to 2023”.


Free sample report contains market size and forecast, drivers,
challenges, trends, and more –
Request for Free Sample @ https://www.technavio.com/talk-to-us?report=Neglected%20Tropical%20Disease%20Treatment%20Market%20by%20Type%20and%20Geography%20-%20Global%20Forecast%20and%20Analysis%202019-2023&type=sample&src=report

Global neglected tropical disease treatment
market: Growing development of non-therapeutic approaches for addressing
the root disease causes

Various preventive measures have been taken to identify and address the
root causes of neglected tropical diseases. People living in rural and
remote areas are more prone to these diseases due to lack of proper
sanitation, clean water, and vector control, in turn, leading to poor
disease control. This calls for the need to identify non-therapeutic
approaches and address the root causes of disease. Such initiatives will
eventually drive market growth during the forecast period.

“Several missions are being initiated to reduce dengue-related
mortality and morbidity in emerging economies including India. These
initiatives involve providing mosquito nets, access to clean water, and
facilitating sustainable sanitation practices. With such initiatives and
approaches, several neglected diseases will be eradicated from advancing
economies,”
says a senior research analyst at Technavio.

Speak to Research Expert @ https://www.technavio.com/talk-to-us?report=Neglected%20Tropical%20Disease%20Treatment%20Market%20by%20Type%20and%20Geography%20-%20Global%20Forecast%20and%20Analysis%202019-2023&type=customization

Global neglected tropical disease treatment
market: Segmentation analysis

This market research report segments the global
neglected tropical disease treatment market
by type (antiparasitic
drugs, antibacterial drugs, and antiviral drugs) and geographic regions
(ROW, Asia, and North America).

ROW led the market in 2018, followed by Asia and North America
respectively. The large market share of ROW can be attributed to the
high prevalence of neglected tropical diseases due to poor sanitation
facilities in the region.

Global neglected tropical disease treatment
market: Initiatives towards increasing awareness and access to medicines

A key factor driving the growth of the global neglected tropical disease
treatment market is the growing initiatives towards increasing awareness
and access to medicines for neglected tropical diseases. Neglected
tropical diseases are infectious diseases that are highly prevalent in
tropical and subtropical countries. The diseases most commonly occur in
the rural populations due to poor housing, improper sanitation, and
unsafe water. Therefore, the high prevalence, has made it necessary for
organizations to raise awareness and increase access to medicines in
these countries. Several organizations including WHO, UNDP, and GHIT are
launching initiatives to improve the access to medicines, vaccines, and
diagnostics for neglected tropical diseases in the low- and
middle-income countries. Such awareness programs across the globe will
eventually drive market growth during the forecast period.

Few Major Players for the Global Neglected Tropical Disease Treatment
Market are:

  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Novartis AG
  • Pfizer Inc.

Browse Industries Reports @ Pharmaceuticals,
Biotechnology & Life Sciences

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at [email protected].

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com